SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-013718
Filing Date
2019-11-07
Accepted
2019-11-07 17:17:00
Documents
78
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gh-09302019x10q.htm 10-Q 1808816
2 EXHIBIT 31.1 gh-0930x2019x10qxexhibit311.htm EX-31.1 12176
3 EXHIBIT 31.2 gh-0930x2019x10qxexhibit312.htm EX-31.2 12352
4 EXHIBIT 32.1 gh-0930x2019x10qxexhibit321.htm EX-32.1 6944
5 EXHIBIT 32.2 gh-0930x2019x10qxexhibit322.htm EX-32.2 7120
  Complete submission text file 0001628280-19-013718.txt   8410197

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gh-20190930.xml EX-101.INS 1875672
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20190930.xsd EX-101.SCH 48795
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gh-20190930_cal.xml EX-101.CAL 103523
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gh-20190930_def.xml EX-101.DEF 264749
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20190930_lab.xml EX-101.LAB 725511
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20190930_pre.xml EX-101.PRE 437629
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38683 | Film No.: 191201335
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences